Publication | Closed Access

Advantages of high b-value diffusion-weighted imaging to diagnose pseudo-responses in patients with recurrent glioma after bevacizumab treatment

Neuro-oncologyRecurrent GliomaOncologic ImagingMedical ImagingMedicineBevacizumab TreatmentBiomedical ImagingTherapeutic ImagingNeuroimagingNeurologyHigh-grade GliomasMri-guided Radiation TherapyOncologyGliomaDiagnostic NeuroradiologyRadiologyHealth Sciences